BDR Pharma launches BDENZA oral solution for prostate cancer
BDENZA will be available at Rs 27,000 for 150mL
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Alembic Pharma received eight USFDA approvals in Q3FY24
The company has received five final approvals and three tentative approvals
Express Pharma January 2024
India's Foremost Pharma & Biotech Magazine ~ Data And Analytics: Driving Value In Pharma Manufacturing
Masterclass with Dr Ajaz S Hussain, Pharma Expert | Regulatory Watch
SMART QbD in ANDAs: Enhancing Assurance of Generic Drug Quality
Venus Remedies gets marketing approval from Israel, Colombia for two oncology drugs
The company has received marketing authorisation for docetaxel from Israel and cytarabine from Colombia
IIL begins construction of greenfield veterinary vaccine facility in Genome Valley, Hyderabad
This unit will have a BSL3 facility for the manufacture of Drug substances and a Fill-Finish capability for the production of both…
India’s fight against rare diseases needs more focus on awareness and diagnosis: GlobalData
In November 2023, the Indian Union Health Ministry authorised the sale of four generic medications for the treatment of rare…
Cell and gene therapy will be top industry trend for pharma in 2024: GlobalData
These therapies promise life-changing treatments for a broad spectrum of complex diseases ranging from genetic conditions to…
Akums launches Doxylamine + Pyridoxine ER tablets
This combination aims to offer an effective tool to manage symptoms of nausea and vomiting during pregnancy
Lupin gets US FDA approval for Loteprednol Etabonate Ophthalmic Suspension, 0.2%
It is indicated for the temporary relief of the signs and symptoms of seasonal allergic conjunctivitis